May 20, 2026 · Form 4 insider transaction
AKKARAJU SRINIVAS bought 14,937 shares of Kalaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents receipt of shares in the distribution in kind described in footnote (3).; Securities are held by Samsara LLC. Dr. Akkaraju has voting and investment power over the shares held by Samsara LLC and, accordingly, may be deemed to beneficially own the shares held by Samsara LLC. Each of the Reporting Persons disclaims beneficial ownership in these shares except to the extent of its or his respective pecuniary interest therein.